Accueil | Fils de syndication

Entêtes d'Actus les + populaires

New Breast Cancer Treatments Help Sufferers Gain Ground [Scientific American Magazine]
Dimanche 18 Mai 2008 - 22:00 - 6 mois depuis - 9 lectures - Presse spécialisée - Scientific American
Breast cancer is the most commonly diagnosed malignancy among women and, after lung cancer, the second leading cause of cancer-related deaths in North America. Yet unlike the survival rate for individuals diagnosed with lung cancer, the rate for women diagnosed with breast cancer has been rising dramatically over the past decade--to the point where breast cancer could soon lose its ranking as the second-greatest cancer killer. Nothing would delight clinicians like us more.This improvement in overall outlook for women diagnosed with breast cancer is attributable in part to earlier detection, which results from greater awareness of, and access to, regular breast screening. But breast cancer patients are also benefiting from accelerated research that has led to a much better understanding of the disease and a wider variety of treatment choices that doctors can mix and match to tailor therapy for a particular patient. In just the past decade, it has even become possible to target drugs to specific molecules within tumors that help to drive the disease. [More]

CORRESPONDENCE: Pursuit of an Expanded Physician Supply
Mercredi 13 Août 2008 - 06:55 - 3 mois, 1 semaine depuis - 9 lectures - Presse spécialisée - New England Journal of Medicin
To the Editor: In his Health Policy Report on physician supply, Iglehart (April 17 issue)1 focuses on a result of ...

CORRESPONDENCE: Glucagon-like Peptide 1-Receptor Scans to Localize Occult Insulinomas
Mercredi 13 Août 2008 - 06:55 - 3 mois, 1 semaine depuis - 9 lectures - Presse spécialisée - New England Journal of Medicin
To the Editor: The precise localization of some insulinomas (islet-cell adenomas that secrete insulin) with the use of conventional imaging ...

Legislation Introduced to Spur Treatments for Brain Ailments [News]
Jeudi 08 Mai 2008 - 15:00 - 6 mois, 2 semaines depuis - 9 lectures - Presse spécialisée - Scientific American
Lawmakers yesterday introduced legislation designed to speed the development of new, safer therapies for brain and nervous system disorders and injuries, which affect an estimated 100 million Americans and costs an estimated $1.3 trillion annually to treat. [More]

REVIEW ARTICLE: Mechanisms of Disease: Effect of In Utero and Early-Life Conditions on Adult Health and Disease
Mercredi 02 Juillet 2008 - 06:55 - 4 mois, 3 semaines depuis - 9 lectures - Presse spécialisée - New England Journal of Medicin
Many lines of evidence, including epidemiologic data and extensive clinical and experimental studies, indicate that early life events play a powerful role in influencing later susceptibility to certain chronic diseases. This review synthesizes evidence from several disciplines to support the contention that environmental factors acting during development should be accorded greater weight in models of disease causation.

Are Personal Genome Scans Medically Useless? [Scientific American Magazine]
Mercredi 07 Mai 2008 - 06:16 - 6 mois, 2 semaines depuis - 9 lectures - Presse spécialisée - Scientific American
For $1,000 and up, several new companies will scan an individual’s entire genome for clues about ancestry, potential health limitations and the inheritance of traits such as lactose intolerance. Clients can compare their DNA with a celebrity’s or invite friends and family members to share genetic profiles. Despite the comprehensive reports and background data these Web-based services deliver, some observers believe the information is more recreational than relevant.Direct-to-consumer genetic tests have existed for at least a decade, and in recent years the number of choices has exploded. Whereas most of these offerings probe for only a small number of gene variants, advances in genome chips now allow a quick, inexpensive search for a wide range of targets all at once. Navigenics in Redwood Shores, Calif., 23andMe in Mountain View, Calif., and deCODE Genetics in Reykjavik, Iceland, recently began scanning for markers associated with as many as two dozen conditions and traits. And for upward of $350,000, Knome in Cambridge, Mass., enables customers to join J. Craig Venter and James D. Watson in the elite cadre of humans who have had their entire genome sequenced, analyzed and interpreted. [More]

Medicare Pays, Even If Providers Do Not
Jeudi 19 Juin 2008 - 21:00 - 5 mois depuis - 9 lectures - Presse généraliste - The Washington Post (health)
Health-care providers are allowed to collect millions of dollars in federal Medicare payments each year despite owing the government more than $2 billion in back taxes, congressional investigators said yesterday.

Virus Outbreak Shakes China [Sciam Observations Blog]
Mercredi 07 Mai 2008 - 05:33 - 6 mois, 2 semaines depuis - 9 lectures - Presse spécialisée - Scientific American
Updated from a May 5 blog entryChinese health-care officials are scrambling to contain the outbreak of a contagious and sometimes deadly intestinal virus--known as Enterovirus 71 (EV71)--that has already claimed the lives of at least 28 children and is likely to continue spreading. [More]

Calif. Court Considers Medical Rights
Mercredi 18 Juin 2008 - 21:00 - 5 mois depuis - 9 lectures - Presse généraliste - The Washington Post (health)
LOS ANGELES -- On the heels of its ruling on same-sex marriage, California's highest court will decide another potentially landmark civil rights case: whether doctors can refuse to treat certain patients for religious reasons.

Psychedelic Healing? [Scientific American Mind]
Vendredi 28 Décembre 2007 - 10:50 - 10 mois, 4 semaines depuis - 9 lectures - Cancer - Scientific American
Mind-altering psychedelics are back--but this time they are being explored in labs for their therapeutic applications rather than being used illegally. Studies are looking at these hallucinogens to treat a number of otherwise intractable psychiatric disorders, including chronic depression, post-traumatic stress disorder, and drug or alcohol dependency.The past 15 years have seen a quiet resurgence of psychedelic drug research as scientists have come to recognize the long-underappreciated potential of these drugs. In the past few years, a growing number of studies using human volunteers have begun to explore the possible therapeutic benefits of drugs such as LSD, psilocybin, DMT, MDMA, ibogaine and ketamine. [More]

Ce site internet met des informations à votre disposition seulement et uniquement dans un but pédagogique. Elles ne peuvent en aucun cas remplacer la consultation d'un médecin ou les soins prodigués par un praticien qualifié et ne doivent par conséquent jamais être interprétés comme pouvant le faire.
Copyright © imedecin
Rental::Voyage::Annuaire web
Médecine et nouvelles technologies::Vidéos médecine::Forum santé

Accueil | Fils de syndication

imedecin.fr

Imedecin.com

Sites imedecin